SMTL ID : 5drp.2 (1 other biounit)

Structure of the AaLpxC/LPC-023 Complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.74, H.226, D.230 Ligands: 5EP.2 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.74, A:H.226, A:D.230, A:D.230

1 x 5EP: N~2~-{4-[4-(4-aminophenyl)buta-1,3-diyn-1-yl]benzoyl}-N-hydroxy-L-isoleucinamide(Non-covalent)

5EP.2: 22 residues within 4Å: Chain A: I.18, H.19, S.59, E.73, H.74, T.179, F.180, A.181, I.186, I.189, K.190, G.195, G.198, S.199, L.200, T.203, V.205, H.226, D.230 Ligands: ZN.1, CL.3, DMS.4 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.18, A:F.180, A:A.181, A:I.186, A:I.189, A:V.205 Hydrogen bonds: A:S.59, A:T.179, A:T.179

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 4 residues within 4Å: Chain A: H.58, S.59 Ligands: 5EP.2, DMS.4 Ligand excluded by PLIP

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.4: 9 residues within 4Å: Chain A: S.59, T.60, E.73, D.230, D.234, H.253, N.256 Ligands: 5EP.2, CL.3 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.256 Salt bridges: A:E.73, A:D.230, A:D.234

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lee, C.J. et al., Drug design from the cryptic inhibitor envelope. Nat Commun (2016)

Release Date

2016-03-09

Peptides

UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase

Related Entries With Identical Sequence